SPONSOR
Asociación para Evitar la Ceguera en México
Total Trials
2
Recruiting
2
Phases
Phase 2, Phase 3
Asociación para Evitar la Ceguera en México is a clinical research sponsor with 2 registered studies on ClinicalTrials.gov, of which 2 are actively recruiting participants. Research covers conditions including Epiretinal Membrane Surgery, Retinopathy of Prematurity.
The trial portfolio spans Phase 2, Phase 3 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Asociación para Evitar la Ceguera en México
How many clinical trials has Asociación para Evitar la Ceguera en México sponsored?
ClinicalMetric currently tracks 2 clinical trials sponsored by Asociación para Evitar la Ceguera en México, of which 2 are actively recruiting participants. These trials cover conditions including Epiretinal Membrane Surgery, Retinopathy of Prematurity. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Asociación para Evitar la Ceguera en México research focus on?
Asociación para Evitar la Ceguera en México clinical trials span Epiretinal Membrane Surgery, Retinopathy of Prematurity. The research pipeline includes Phase 2, Phase 3 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Asociación para Evitar la Ceguera en México clinical trial?
To participate in a Asociación para Evitar la Ceguera en México trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Asociación para Evitar la Ceguera en México trials with current recruitment status updated daily.
Clinical Trials by Asociación para Evitar la Ceguera en México
NCT07095907
Recruiting
Post-surgical Functional Results in Patients With Epiretinal Membrane Undergoing Controlled Macular Detachment
Epiretinal Membrane Surgery
NCT00346814 Phase 2, Phase 3
Recruiting
Antiangiogenic Therapy With Bevacizumab in Retinopathy of Prematurity. Structural Outcome
Retinopathy of Prematurity
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology